Finapres systems are used to easily and non-invasively
optimize the atrioventricular delay in cardiac resynchronization therapy (CRT).
The changes in systolic blood pressure are monitored as atrioventricular (AV)
delays are changed. By increasing AV delay from 40ms to 320ms initially the
blood pressure will increase. Increasing AV delay beyond its optimum value will
cause blood pressure to drop again. Non-invasive hemodynamic evaluation
prevents cumbersome and lengthy ultrasound measurements or invasive blood
pressure measurements.
- A non-invasive, automated, guided protocol.
- CRT optimisation to be done efficiently and effectively in just 20
minutes.
- Reproducible results without the need for echo cardiography.
- The recent BRAVO Trial describes the TrueMax method to
measure haemodynamic effects from guided changes in AV delay.
- TrueMax protocol is also suitable for His bundle pacing
optimisation.